Skip to: Content
Skip to: Site Navigation
Skip to: Search

July 25, 2008 5:45:06 PM CDT

Learn about Newser Points »

« Back to the grid | Next story »

Americans Go Abroad, Online for New Diet Pill

Posted Jun 11, 07 8:21 PM CDT in US,  Science & Health,  Glossies 

(Newser) – The weight loss drug Acomplia is stuck in FDA limbo, but that isn't stopping Americans from ordering it off the Internet or buying it in Europe, where it's legal. If the government rules that its lowering of weight and cholesterol balances out the possible side effects, including suicide and depression, Acomplia could be worth billions to manufacturer Sanofi-Aventis.

Acomplia will be sold as Zimulti in the US, where one-third of the population is obese. The drug stifles hunger by blocking brain receptors and interacts directly with fat cells. The FDA was originally expected to rule on the drug last year, Bloomberg reports; safety questions have forced three postponements, and a decision is now expected next month.

Source Bloomberg

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon

Related Newser Stories

  • FDA Advisory Panel Rejects Weight-Loss Drug

    Jun 14, 07 6:41 AM CDT
    FDA Advisory Panel Rejects Weight-Loss Drug Accomplia, a weight-loss drug marketed in 18 other countries, failed to win approval from an FDA advisory board yesterday. The 14-member panel of outside experts ruled unanimously that manufacturer Sanofi-Aventis had not dispelled concerns about the safety of the drug, whose potential side effects include suicidal thoughts, anxiety, and depression. More »

  (Getty Images)
  (Getty Images)
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Threads (1 of 4)

Tags

FDA  • medicine  • suicide  • depression  • weight loss  • obesity epidemic  • cholesterol  • diet pills  • Sanofi Aventis  • Acomplia


Loading...

Loading...

Today's Most Popular


Other Home Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »